Page 355 - Read Online

Raevsky et al. Neuroimmunol Neuroinflammation 2018;5:44 Neuroimmunology and
DOI: 10.20517/2347-8659.2018.61 Neuroinflammation

Correction Open Access

Correction: In silico design of novel gold-phosphate
containing compounds as selective inhibitors of
cathepsin B in neuroinflammation

Alexsey V. Raevsky , Mohsen Sharifi , Vasily Pinchuk , Andis Klegeris 5
1
2,3
4
1 Laboratory of Structural Biology, Institute of Food Biotechnology and Genomics, National Academy of Sciences of Ukraine, Kyiv 04123,
Ukraine.
2 Medway School of Pharmacy, Universities of Kent and Greenwich, Kent ME4 4TB, UK.
3 Present address: Division of Systems Biology, National Center for Toxicological Research, US Food and Drug Administration, Jefferson,
AR 72079, USA.
4 Life Chemicals Ltd., Niagara-on-the-Lake, ON L0S 1J0, Canada.
5 Department of Biology, University of British Columbia, Okanagan Campus, Kelowna, BC V1V 1V7, Canada.
Correspondence to: Dr. Alexsey V. Raevsky, Laboratory of Structural Biology, Institute of Food Biotechnology and Genomics, National
Academy of Sciences of Ukraine, Kyiv 04123, Ukraine. E-mail: o.v.raievskyi@imbg.org.ua; Dr. Andis Klegeris, Department of Biology,
University of British Columbia, Okanagan Campus, Kelowna, BC V1V 1V7, Canada. E-mail: andis.klegeris@ubc.ca
How to cite this article: Raevsky AV, Sharifi M, Pinchuk V, Klegeris A. In silico design of novel gold-phosphate containing compounds
as selective inhibitors of cathepsin B in neuroinflammation. Neuroimmunol Neuroinflammation 2018;5:44.
http://dx.doi.org/10.20517/2347-8659.2018.61
Revised: 28 Sep 2018 Accepted: 30 Sep 2018 Published: 22 Oct 2018

The original article was published on 27 Aug 2018.

Dr. Mohsen Sharifi declares the view presented in the article are those of the authors and do not reflect those of
the US Food and Drug Administration. No official endorsement is intended nor should be inferred.

© The Author(s) 2018. Open Access This article is licensed under a Creative Commons Attribution 4.0
International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long
as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license,
and indicate if changes were made.

www.nnjournal.net